CD8A and neoplasm: Chemotherapy-induced immunogenic cell death (ICD) promotes the maturation and activation of dendritic cells (DCs), enabling them to present tumor antigens to CD8+T cells, thereby activating specific cytotoxic T lymphocyte responses (24).